INS and diabetic kidney disease: Gautam et al. validated the traditional pharmacological claim of Momordica charantia in alleviating diabetic nephropathy and its associated complications via regulation of several pathophysiological pathways such as metabolic regulation, increased uptake of glucose to the muscle, obviating insulin resistance, biochemical markers regulation, oxidative stress, and inflammation, etc. [34].